Cardinal Health 108, LLC

Dublin, OH Doing business as Metro Medical Supply Part of Cardinal Health, Inc.

UEI
Q1DZKR8YJ6L5
CAGE
82MX8
Primary NAICS
424210 Drugs and Druggists' Sundries Merchant Wholesalers
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Cardinal Health, Inc., ranks:

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Other
Corporate family
SAM.gov registration date
Physical address
7000 Cardinal Pl #113, Dublin, OH 43017, USA
Founded
1971
Employees
10K-50K
Estimated annual revenue
$10B+
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $219,131
FY2026 $812,238
FY2025 $324,498
FY2024 $407,999
FY2023 $129,734

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $824,305
2 Department of Health and Human Services $207,065

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Cardinal Health 108, LLC, doing business as Metro Medical Supply, supplies specialty pharmaceuticals and radiopharmaceuticals exclusively to federal healthcare agencies as a prime contractor, competing on a full-and-open, unrestricted basis without set-aside participation. The company is a Dublin, Ohio-based subsidiary of Cardinal Health, Inc., a global healthcare services and products company, and operates as a for-profit limited liability company under NAICS 325412 (Pharmaceutical Preparation Manufacturing), with 48 of 53 recent awards concentrated in pharmaceutical manufacturing and distribution.

Cardinal Health 108's federal footprint centers on the Department of Veterans Affairs across multiple Veterans Integrated Service Networks and the National Institutes of Health Clinical Center. The top three customer agencies by combined potential value account for 97% of recent awards: VISN 20 (5 awards, $2.9 million combined potential value), NIH Clinical Center (6 awards, $1.5 million), and VISN 2 (30 awards, $605 thousand). Customer concentration by award count is markedly different—VISN 2 dominates volume with 30 individual purchase orders, each typically valued under $40,000, while VISN 20 anchors the largest dollars through a single-award Indefinite Delivery Contract for radiopharmaceuticals. The company has served nine distinct federal agencies since 2018, with activity concentrated among VA networks and NIH.

Cardinal Health 108's primary vehicle is an Indefinite Delivery Contract (36C26025D0007) with VISN 20 valued at $2.164 million through October 31, 2029, supporting nuclear medicine radiopharmaceuticals for VA patients. Two delivery orders have been placed against this IDC: $147,818.52 (awarded November 1, 2024, completion October 31, 2025) and $209,272.21 (awarded November 1, 2025, completion October 31, 2026), together totaling $357,090.73 in called work. The remaining portfolio consists of individual purchase orders, predominantly emergency or routine pharmaceutical procurements for specific medications at named VA medical centers.

Representative work includes a $2.164 million single-award IDIQ with VISN 20 for radiopharmaceuticals supporting nuclear medicine treatments through October 2029; a $207,064.87 sole-source purchase order from NIH Clinical Center (February 2026) for Sirturo (bedaquiline) tablets, awarded without competitive solicitation because Cardinal Health holds manufacturer's exclusive U.S. distributor status; and recurring purchase orders from VISN 2 for specialty pharmaceuticals including Livtencity (maribavir), Jelmyto (mitomycin), Arcalyst (rilonacept), Zusduri kits, and Korsuva, typically valued between $3,700 and $37,482 per order, many designated as emergency procurements with turnaround times of one to four weeks.

Activity has accelerated sharply—7 awards in 2022, 6 in 2023, 3 in 2024, then 16 in 2025 and 15 in 2026—driven primarily by high-frequency small-dollar emergency pharmaceutical orders from VISN 2. Combined potential value across all 53 awards is $5.7 million, with $3.5 million already obligated (61% of potential value). Three awards with ultimate completion dates in the next twenty-four months carry combined potential value of $475 thousand, representing modest recompete exposure given the modular nature of individual purchase orders. The company operates from Dublin, Ohio, with all place-of-performance locations at Cardinal Health 108's distribution facility or at specific VA medical centers receiving the ordered products. Cardinal Health 108 executes all work as a prime contractor with no subcontract footprint in the source data.

Quick answers

Is Cardinal Health 108, LLC registered in SAM.gov?

Yes. Cardinal Health 108, LLC's SAM.gov registration is active through September 23, 2027.

How much has Cardinal Health 108, LLC received in federal contracts?

Federal contracts obligated $324,498 to Cardinal Health 108, LLC in fiscal year 2025 and $1,893,601 in fiscal years 2023 through 2027.

How does Cardinal Health 108, LLC rank among federal contractors?

Cardinal Health 108, LLC's parent company, Cardinal Health, Inc., ranked #15 in NAICS 325412, #17 in NAICS 3254 and #17 in PSC 6505 in FY2025.

What is Cardinal Health 108, LLC's most recent federal award?

Cardinal Health 108, LLC's most recent federal contract award is Radiopharmaceuticals for nuclear medicine VA patients (36C26027N0023), from Veterans Integrated Service Network 20 (VHA), on November 1, 2026.

On GovTribe

See Cardinal Health 108, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors